Skip to main navigation
  • Recent News
  • Investors
  • Contact Us
Avadel pharmaceutical logo
  • Home
  • About Us
  • Our Focus
  • Culture & Careers
  • Recent News
  • Investors
  • Contact Us

Breadcrumb

  1. Home
  2. Investors
  3. Mark McCamish, M.D., Ph.D.

Biography

« Back
Mark A. McCamish M.D., Ph.D.
Director
Dr. Mark A. McCamish has been a member of the Avadel Board of Directors since December 2019. Dr. McCamish is currently the President and Chief Executive Officer of IconOVir Bio, a preclinical-stage biotechnology company pioneering the next generation of oncolytic virus (OV) therapy to improve the treatment of patients with cancer. Prior to IconOVir, Dr. McCamish served as President, Chief Executive Officer, and member of the Board of Directors of Forty Seven, Inc, a clinical-stage biopharmaceutical company. From July 2009 to April 2017, Mark served as Global Head of Biopharmaceutical Development at Sandoz Inc., a pharmaceutical company. He has over 25 years of experience in corporate management, clinical and pharmaceutical research, and academics. Mark received both a BA in physical education and an MA in ergonomics from the University of California at Santa Barbara, a PhD in nutritional sciences from Pennsylvania State University and an MD from University of California at Los Angeles.
  • Member of the Audit Committee
  • Member of the Compensation Committee

Tools

  • Print Page
  • RSS
  • E-mail Alerts

Investor Relations

  • Investors
  • News & Events
    • Press Releases
    • Events
    • Presentations
  • Stock Information
    • Stock Quote & Chart
    • Historical Price Lookup
    • Investment Calculator
    • Analyst Coverage
  • Financial Information
    • SEC Filings
    • Financial Reports
    • Quarterly Results
  • Corporate Governance
    • Governance Highlights
    • Management Team
    • Board of Directors
    • Committee Composition
    • Annual General Meeting
  • Shareholder Services
    • Investor FAQs
    • Information Request
    • E-mail Alerts
    • IR Contacts
  • About Us
  • Our Focus
  • Culture & Careers
  • Recent News
  • Investors
  • Contact Us
  • Home
  • About Us
  • Our Focus
  • Culture & Careers
  • Contact Us
  • Recent News
  • Investors
  • Privacy Policy
  • Corporate Compliance
  • Terms and Conditions

Avadel, the Avadel logo, the droplet brand mark, and other brands are trademarks of an Avadel company. © 2022 Avadel. All rights reserved.

PM-US-AVGEN-0132

We Care About Your Privacy

This website uses cookies. By using our website without changing your cookie settings, you agree to our use of cookies as described in our updated Privacy Policy.

You are about to leave the Avadel website.

Do you want to continue?

Avadel is not responsible for the content or availability of third party sites.